Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Study of Chemoradiotherapy Using Gemcitabine Plus Nab-paclitaxel for Unresectable Locally Advanced Pancreatic Adenocarcinoma

NCT02272738 is registered in ClinicalTrials.gov with Osaka Medical Center for Cancer and Cardiovascular Diseases as lead sponsor.

NCT NCT02272738
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02272738 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Study of Chemoradiotherapy Using Gemcitabine Plus Nab-paclitaxel for Unresectable Locally Advanced Pancreatic Adenocarcinoma
Lead sponsor
Osaka Medical Center for Cancer and Cardiovascular Diseases
Phase
Phase 1
Overall status
Completed
Start date
August 31, 2013
Completion date
April 30, 2016
Enrollment
54 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic cancer